Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference71 articles.
1. French AFU Cancer Committee Guidelines – update 2022–2024: prostate cancer – diagnosis and management of localised disease;Ploussard;Prog Urol,2022
2. Incidence and mortality trends of metastatic prostate cancer: surveillance, epidemiology, and end results database analysis;Zhang;Can Urol Assoc J,2021
3. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design;Fizazi;Lancet,2022
4. Characterization of differences between prostate cancer patients presenting with de novo versus primary progressive metastatic disease;Finianos;Clin Genitourin Cancer,2017
5. French AFU Cancer Committee Guidelines – Update 2022-2024: prostate cancer – management of metastatic disease and castration resistance;Ploussard;Prog Urol,2022